AI Assistant
Blog
Pricing
Log In
Sign Up
A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
